BridgeMD
New treatment option for Intellectual Disability
Official title A Computer-based Cognitive Remediation Program for Adults With Intellectual Disability
ClinicalTrials.gov ID: NCT04025398
What this study is testing
- What it's testing
- Adults with intellectual disabilities have great difficulty in adapting to social situations and relationships. Cognitive impairment associated with intellectual disability are important factors to understand their difficulties in processing social information.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 45
You may be able to join if
- Adults aged 18 to 45 inclusive;
- Behavioral disorders corresponding to a total score on the ABC scale \> 15
- Presence of a family caregiver (parent, friend) or professional (reeducator, professional of the medico-social sector) stakeholder of the project;
- Diagnosis of mild to moderate intellectual disability (assessed by WAIS-IV battery and VABS-II less than 3 years ago;
- French or secondary mother tongue;
You likely can't join if
- Neurological disorders of vascular, infectious or neurodegenerative origin;
- Taking medications for general medical purposes with a neurological or psychiatric impact (eg corticosteroids);
- Simultaneous participation in any other cognitive remediation program targeting attentional, visuospatial and social cognition;
- Refusal of participation of the person and/or his/her legal representative;
- Not family or professional caregiver;
- Presence of Autistic Spectrum Disorders (evaluated by ADOS and ADI if necessary according to the assessment of the investigator)
See the full eligibility criteria
- Adults aged 18 to 45 inclusive;
- Behavioral disorders corresponding to a total score on the ABC scale \> 15
- Presence of a family caregiver (parent, friend) or professional (reeducator, professional of the medico-social sector) stakeholder of the project;
- Diagnosis of mild to moderate intellectual disability (assessed by WAIS-IV battery and VABS-II less than 3 years ago;
- French or secondary mother tongue;
- Psychoactive treatment unchanged during the month prior to inclusion;
- Adult or legal representative who has given written and informed consent to participate in the study. By default, the adult's oral agreement will be collected (as well as the written consent of the legal representative);
- Affiliation to the social security scheme or beneficiary of such a scheme.
- Neurological disorders of vascular, infectious or neurodegenerative origin;
- Taking medications for general medical purposes with a neurological or psychiatric impact (eg corticosteroids);
- Simultaneous participation in any other cognitive remediation program targeting attentional, visuospatial and social cognition;
- Refusal of participation of the person and/or his/her legal representative;
- Not family or professional caregiver;
- Presence of Autistic Spectrum Disorders (evaluated by ADOS and ADI if necessary according to the assessment of the investigator)
The study team makes the final eligibility decision.
Where it's taking place
- Lyon, Auvergne-Rhône-Alpes, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 45 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Lyon, Auvergne-Rhône-Alpes, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.